Talk:Lirilumab
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lirilumab.
|
Probably not the same as mAb 1-7F9
[edit]This article uses a ref about 1-7F9 which according to [1] is a different anti-KIR mAb. - Rod57 (talk) 16:24, 8 February 2017 (UTC)